Share-split context: A reverse split was recorded on Sep 2, 2025 with coefficient 0.333333. A reverse split combines multiple old shares into fewer new shares and mechanically raises the quoted price per share. That mechanical increase does not restore lost investment value. The returns in this report are already split-adjusted, while reverse-split history remains a separate structural warning.

What this ETF is trying to do

The GLOBAL X HEALTHTECH ETF (ticker: HEAL) focuses on the intersection of healthcare and technology. It invests in companies that use advanced tech to improve health services. Based on its top holdings, the fund includes companies like Oscar Health Inc Class A, IQVIA Holdings Inc, and Veeva Systems Inc Class A. Because the provided list is partial, these are considered "Top Holdings" rather than all the companies in the fund.

What the numbers show

The performance of HEAL shows different results depending on how you measure it:

• Year-to-Date (YTD): The price return is -0.64%. Since the total return is also -0.64%, there was no difference between the share price change and the total return so far this year.

• One-Year: The share price (price return) fell by approximately 11.64%. However, the one-year total return was -11.42%.

• Three-Year: Over a three-year period, the share price rose by approximately 8.47%, while the total return was higher at approximately 8.82%.

• Five-Year: The five-year total return is -45.07%.

It is important to note that this ETF has a history of a reverse split. In a reverse split, multiple old shares are combined into fewer new shares. This causes the price per share to rise mechanically, but it does not increase the actual value of the investment.

Income and distribution explanation

HEAL has a distribution yield of approximately 0.25%. This represents the cash distributions paid out relative to the ETF's price. The fund has an "irregular" or less frequent distribution frequency, with only one payout recorded in the last 12 months. Because the yield is quite low, this ETF is not primarily designed to provide high levels of regular income.

NAV erosion explanation

The supplied data is sufficient to evaluate price erosion, but it does not include enough historical NAV-per-share data to confirm or rule out NAV erosion.

Regarding price movement, the fund has an erosion-risk score of 75, which is labeled as "Mild price erosion." This is a measurement of price-based risk and is not a "severe erosion-risk flag," which remains false.

Pros

• Three-Year Growth: The fund has shown positive total returns over a three-year period.

• Specific Sector Focus: It provides targeted exposure to the health-technology industry through various specialized companies.

Cons

• Recent Price Declines: The fund has experienced a share-price decline over the last year.

• Low Income: The distribution yield is low, and the payout frequency is irregular.

• Five-Year Performance: The five-year total return shows a significant decline.

Beginner takeaway

When looking at HEAL, it is important to distinguish between price return (how the share price moves) and total return (which includes distributions). While the fund has seen growth over three years, it has faced price declines over the last year and a much larger decline over five years. Additionally, because this fund has undergone a reverse split in the past, investors should look at total percentage returns rather than just looking at the share price to understand performance.